-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
-
Summary
-
Lifecore Biomedical, Inc. \De\ quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2012 to Q2 2024.
- Lifecore Biomedical, Inc. \De\ Deferred Tax Assets, Valuation Allowance for the quarter ending May 26, 2024 was $46.2M, a 12.1% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)